Cargando…

Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma

PURPOSE: The purpose of this study is to investigate the clinical significance of tyrosine hydroxylase (TH) expression in peripheral blood (PB) at diagnosis in patients with neuroblastoma. MATERIALS AND METHODS: TH mRNA expression in PB was measured by reverse transcription quantitative real-time po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Na Hee, Son, Meong Hi, Choi, Young Bae, Yi, Eunsang, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080821/ https://www.ncbi.nlm.nih.gov/pubmed/27034145 http://dx.doi.org/10.4143/crt.2015.481

Ejemplares similares

Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population
por: Lim, Hana, et al.
Publicado: (2020)

Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
por: Bae, Soo Jin, et al.
Publicado: (2012)

Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2015)

Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma
por: Bae, Joon Seol, et al.
Publicado: (2022)

Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma
por: Choi, Young Bae, et al.
Publicado: (2019)

Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors
por: Yi, Eun Sang, et al.
Publicado: (2012)

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
por: Lee, Eunjin, et al.
Publicado: (2020)

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
por: Kim, Chiwoo, et al.
Publicado: (2018)

Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
por: Seo, Eunseop, et al.
Publicado: (2019)

Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children
por: Bae, Joon Seol, et al.
Publicado: (2020)

Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Erratum: Correction of Title: Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Neuroblastoma Originating from Extra-abdominal Sites: Association with Favorable Clinical and Biological Features
por: Sung, Ki Woong, et al.
Publicado: (2009)

Hematologic Recovery after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk Solid Tumors
por: Son, Meong Hi, et al.
Publicado: (2013)

ARID1B alterations identify aggressive tumors in neuroblastoma
por: Lee, Soo Hyun, et al.
Publicado: (2017)

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
por: Lee, Ji Won, et al.
Publicado: (2022)

Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL
por: Kim, Hye Ryung, et al.
Publicado: (2012)

MBCL-28. LONG-TERM FOLLOW-UP RESULTS OF REDUCED DOSE CRANIOSPINAL RADIOTHERAPY AND TANDEM HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK MEDULLOBLASTOMA
por: Lee, Ji Won, et al.
Publicado: (2020)

Inhibition of N‐myc expression sensitizes human neuroblastoma IMR‐32 cells expressing caspase‐8 to TRAIL
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions
por: Lee, Myoung Woo, et al.
Publicado: (2013)

Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
por: Lee, Ji Won, et al.
Publicado: (2017)

Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma
por: Seo, Eun Seop, et al.
Publicado: (2020)

Gene Expression Profiles of Human Adipose Tissue-Derived Mesenchymal Stem Cells Are Modified by Cell Culture Density
por: Kim, Dae Seong, et al.
Publicado: (2014)

Effect of Ex Vivo Culture Conditions on Immunosuppression by Human Mesenchymal Stem Cells
por: Lee, Myoung Woo, et al.
Publicado: (2013)

Neuroblastoma: an ongoing cold front for cancer immunotherapy
por: Kennedy, Paul T, et al.
Publicado: (2023)

Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors
por: Sung, Ki Woong, et al.
Publicado: (2014)

High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas
por: Choi, Young Bae, et al.
Publicado: (2016)

Therapy-related myeloid neoplasms in children and adolescents
por: Cho, Hee Won, et al.
Publicado: (2016)

Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
por: Sung, Ki Woong, et al.
Publicado: (2002)

Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
por: Cho, Hee Won, et al.
Publicado: (2018)

High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center
por: Suh, Jung Min, et al.
Publicado: (2009)

Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy
por: Kim, Jinsup, et al.
Publicado: (2015)

Excellent outcome of medical treatment for Kasabach-Merritt syndrome: a single-center experience
por: Kim, Jin Ah, et al.
Publicado: (2016)

Strategies to improve the immunosuppressive properties of human mesenchymal stem cells
por: Lee, Myoung Woo, et al.
Publicado: (2015)

NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia
por: Yi, Eun Sang, et al.
Publicado: (2018)

The expression and significance of tyrosine hydroxylase in the brain tissue of Parkinsons disease rats
por: Chen, Yuan, et al.
Publicado: (2017)

The local expression and trafficking of tyrosine hydroxylase mRNA in the axons of sympathetic neurons
por: Gervasi, Noreen M., et al.
Publicado: (2016)

Plasma dopamine-beta-hydroxylase in neuroblastoma.
por: Schöni, M., et al.
Publicado: (1984)

Genetic Variations of Tyrosine Hydroxylase in the Pathogenesis of Hypertension
por: Lee, Yu Ho, et al.
Publicado: (2016)

Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Lee, Sae-Mi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b48pd3ltm2i607qh1js46i5g2v